DBP and COVID-19: However, few other studies with low-grade evidence have reported a non-significant effect of VD in COVID-19.This controversy surrounding the clinical outcomes of VD supplementation in the treatment of COVID-19 can be explained by VDR gene polymorphisms, DBP gene polymorphisms and impaired VDR signaling as non-genetic causes.